证券记录 · 已归档季度
PRAX
Praxis Precision Medicines, Inc. · Healthcare · Biotechnology
12被追踪持有人
—Δ持有人
4.09M持有股份
$168.97M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +10 | 16.57M | $5.55B | +16 | −5 |
| Q1 2026 | 103 | +2 | 17.55M | $5.65B | +11 | −10 |
| Q4 2025 | 101 | +1 | 18.04M | $5.32B | +2 | — |
| Q3 2025 | 17 | +1 | 10.82M | $573.60M | +1 | −1 |
| Q2 2025 | 14 | 0 | 8.51M | $357.72M | +1 | −1 |
| Q1 2025 | 11 | -2 | 4.62M | $175.13M | — | −2 |
| Q4 2024 | 13 | 0 | 4.07M | $313.25M | — | — |
| Q3 2024 | 12 | 0 | 3.95M | $227.16M | +1 | −1 |
| Q2 2024 | 12 | — | 4.09M | $168.97M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.13M | — | $46.91M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 1.05M | — | $43.50M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 938.58K | — | $38.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 938.58K | — | $38.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 395.06K | — | $16.34M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 395.06K | — | $16.34M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 248.38K | — | $10.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 248.38K | — | $10.27M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 90.91K | — | $3.76M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 75.43K | — | $3.12M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (被动) | 32.01K | — | $1.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 23.97K | — | $991,234 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 22.65K | — | $936,639 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 21.08K | — | $871,745 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 287 持有人, 28.34M 股份, $8.85B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据